XML 40 R30.htm IDEA: XBRL DOCUMENT
v3.23.2

Net Income (Loss) per Share (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2023
Earnings Per Share [Abstract] |
Schedule of Securities Not Included in Diluted per Share Calculations | Securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in shares):
|  | For the Three and Six Months Ended June 30, |
|  | 2023 |  |  | 2022 |
Options to purchase common stock |  |  | 84,755 |  |  |  | 57,092 |
Warrants to purchase common stock |  |  | 266,957 |  |  |  | 283,751 |
Preferred investment options |  |  | 1,489,952 |  |  |  | — |
Total |  |  | 1,841,664 |  |  |  | 340,843 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration